Literature DB >> 19621611

[Investigation of the presence of human papillomavirus DNA in various gastrointestinal carcinoma samples].

Deniz Erol1, Yasemin Bulut, Hüseyin Yüce, Ibrahim Hanifi Ozercan.   

Abstract

The role of human papillomavirus (HPV) has been well established in the pathogenesis of cervical cancers. However, HPV-DNA has also been detected in tumor tissues of other malignancies. Recently, detection of HPV-DNA in gastrointestinal cancer tissues with in-situ hybridization and PCR technologies has suggested possible role of HPV in gastrointestinal cancers. In this study, it was aimed to investigate the presence of HPV in the tumor tissues and adjacent normal tissues of gastrointestinal cancers and to determine the types of HPV in positive cases. The study included a total of 106 (59 male, 47 female, age range: 25-80 years, mean age: 57.03 +/- 1.29 years) patients, of them 38 had gastric, 42 colon, 20 rectal, 4 esophageal and 2 small intestinal cancers. Genomic DNAs were isolated from the parafin embedded specimens of tumor and tumor-adjacent normal tissues and the performance of the extraction process was controlled with PCR using beta-globin primer. DNA extraction was achieved in 100 of the tumor tissues and in all of the tumor adjacent normal tissues (n=106). HPV-DNA was searched by,using GP5/GP6 primers and concensus PCR method. HPV-positive DNA samples were further typed by using HPV-11, 16, 18, 33 specific primers. HPV-DNA was detected in 41% (41/100) of tumor tissue samples and 31% (33/106) of tumor-adjacent normal tissue samples. There was no statistically significant difference in terms of HPV-DNA positivity between tumor and tumor-adjacent normal tissues (p > 0.05). HPV-DNA was detected in 44.7% (33/106) of gastric samples, 35.1% (13/37) of colon samples, 47.3% (9/19) of rectal samples, 25% (1/4) of esophagus samples and 50% (1/2) of small intestine samples. Eight of the HPV positive tumor tissues revealed HPV type 16, three type 18 and five type 33, while three of normal tissue samples revealed type 18 and two type 33. Two different HPV types together were detected in two tumor samples, one being type 16 + type 33 and the other being type 18 + type 33. Although these results indicating the presence of HPV-DNA in gastrointestinal tumor and adjacent normal tissues, suggest a possible role of HPV in gastrointestinal tumors, further studies are necessary for the establishment of a definite causative role.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19621611

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  5 in total

1.  Detection of human papillomavirus DNA in gastric carcinoma specimens in a high-risk region of Iran.

Authors:  Farzaneh Fakhraei; Mohammad Reza Haghshenas; Vahid Hosseini; Alireza Rafiei; Farshad Naghshvar; Reza Alizadeh-Navaei
Journal:  Biomed Rep       Date:  2016-07-29

2.  Detection of human papillomavirus infection by molecular tests and its relation to colonic polyps and colorectal cancer.

Authors:  Faten Gazzaz; Mahmoud H Mosli; Hani Jawa; Abdulrahman Sibiany
Journal:  Saudi Med J       Date:  2016-03       Impact factor: 1.484

Review 3.  Association between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: a meta-analysis.

Authors:  H A Hardefeldt; M R Cox; G D Eslick
Journal:  Epidemiol Infect       Date:  2014-06       Impact factor: 4.434

4.  Association between Helicobacter pylori, Epstein-Barr virus, human papillomavirus and gastric adenocarcinomas.

Authors:  Carolina Rosal Teixeira de Souza; Marcelli Carolini Alves Almeida; André Salim Khayat; Emerson Lucena da Silva; Paulo Cardoso Soares; Luiz Cláudio Chaves; Rommel Mario Rodríguez Burbano
Journal:  World J Gastroenterol       Date:  2018-11-21       Impact factor: 5.742

5.  Associations Between Gastric Cancer Risk and Virus Infection Other Than Epstein-Barr Virus: A Systematic Review and Meta-analysis Based on Epidemiological Studies.

Authors:  Hui Wang; Xiao-Long Chen; Kai Liu; Dan Bai; Wei-Han Zhang; Xin-Zu Chen; Jian-Kun Hu
Journal:  Clin Transl Gastroenterol       Date:  2020-07       Impact factor: 4.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.